Efficacy and Safety of Mecobalamin Combined with Prokinetic Agents in the Treatment of Diabetic Gastroparesis: A Meta-Analysis
-
Jia Yao
,
Bo Peng
,
Xia yu Gong
,
Xiaoyan Shi
,
Simin Fan
,
Qiu Chen
Abstract
Background: The aim of the present study was to systematically review the efficacy and safety of mecobalamin combined with prokinetic agents in diabetic gastroparesis (DGP).
Methods: A variety of databases were searched from inception to Nov 2, 2018. RCTs of mecobalamin combined with prokinetic agents group (experimental group) versus prokinetic agents only group (control group) in DGP were included. RevMan 5.3 and Stata 12.0 were used to perform the meta-analysis. Finally, 24 RCTs with 1,878 patients were included.
Results: The total efficacy rate was significantly higher in the experimental group (mecobalamin combined with prokinetic drugs) compared with the control group (prokinetic drugs alone) (P<0.001), and the improvement was observed regardless of the administration route. Furthermore, the treatment group exhibited a significantly improved gastric emption rate (P<0.001), motilin (P<0.001) and recurrence rate (P<0.001), and there was no statistical difference in the incidence of adverse reactions between two groups (P=0.49).
Conclusion: Mecobalamin combined with prokinetic agents can significantly improve total efficacy rate and gastric emptying rate, decrease serum motilin and the recurrence rate without increasing adverse reactions in DGP. Thus, mecobalamin may can be used as a new therapeutic option for DGP.
2. Ma J, Rayner CK, Jones KL et al (2009). Di-abetic gastroparesis: diagnosis and man-agement. Drugs, 69(8):971-986.
3. Higgins JPT, Green S, editor(s) (2011). Cochrane Handbook for Systematic Re-views of Interventions, Version 5.1.0. The Cochrane Collaboration 5: S38. https://handbook-5-1.cochrane.org/
4. An JF (2018). The efficacy of mecobalamin combined with mosapride in treating di-abetic gastroparesis. Guidelines for Health Care, 28:11,13.
5. Du F (2015). The efficacy of mecobalamin combined with domperidone treatment in diabetic gastroparesis. Diabetes New World, 16:19-20.
6. Gu XM, Jiang CJ (2015). Comparing the ef-ficacy of mecobalamin combined with mosapride and mosapride alone in dia-betic gastroparesis. Frontiers of Medicine, 10:194-195.
7. Guan LY (2013). Observation of the effica-cy of mecobalamin combined with mosapride in diabetic gastroparesis. Chi-nese Practical Medicine, 8(35):120-121.
8. Guo L, Zheng YH, Tan WY et al (2017). Effect of mecobalamin combined with domperidone in diabetic gastroparesis. Northern Pharmacy, 14(10):47.
9. Huang RX (2012). Observation on the effi-cacy of mecobalamin combined with mosapride in diabetic gastroparesis. Chi-nese Medical Journal, 47(03):60-61.
10. Jin JY (2015). Observation of the effect of mosapride combined with mecobalamin in diabetic gastroparesis. Chinese Rural Medicine, 22(05):26,49.
11. Li BZ (2013). Clinical efficacy of the treat-ment of diabetic gastroparesis by meco-balamin combined with cisapride. Journal of Henan Staff Medical College, 25(06):701-702.
12. Li Q, Huang C, Huang Y (2012). Effect of mecobalamin and mosapride in treating diabetic gastroparesis. Chinese Medical Inno-vation, 9(23):23-24.
13. Li X, Bai J (2012). Observation on the ef-fects of mecobalamin combined with etopril in diabetic gastroparesis. Chinese Community Physician (Medical Specialty), 14(06):21.
14. Liu R, He CC (2009). Clinical observation of mecobalamin combined with mosapride in diabetic gastroparesis. Journal of the Fourth Military Medical University, 30(02):168.
15. Mao H, Wang YJ (2017). Effects of ginaton combined with mosapride and mecobal-amin in treatment of DGP. Southwest De-fense Medicine, 27(06):577-579.
16. Qiao Y, Wu YW, Hao M (2009). Treatment of mecobalamin in combination with cis-apride for diabetic gastroparesis: an anal-ysis of 72 cases. World Chinese Journal of Di-gestion, 17(02):202-204.
17. Ren L (2010). Efficacy of mecobalamin combined with mosapride in treating 45 cases of diabetic gastroparesis. Shanxi Journal of Medicine, 39(09):1225-1226.
18. Shi Y (2018). Efficacy of mosapride alone and combined with mecobalamin in dia-betic gastroparesis. Health Care Guidelines, 1:251.
19. Sun SD (2011). Observation on the effect of mecobalamin combined with etopril in diabetic gastroparesis. Qingdao University, 1-13.
20. Tian DZ, Li ST, Song LS (2006). Clinical observation on the treatment of meco-balamin combined with cisapride in dia-betic gastroparesis. Zhongyuan Medical Jour-nal, 10:78.
21. Wang C (2013). Efficacy of mecobalamin combined with domperidone in diabetic gastroparesis. Chinese Pharmacy, 24(24):2258-2260.
22. Wu Q, Wang LC (2009). Clinical observa-tion on the treatment of mosapride combined with mecobalamin in diabetic gastroparesis. Jilin Medicine, 30(23):2960.
23. Wu ZY (2016). Effect of mosapride com-bined with mecobalamin in diabetic gas-troparesis. China Journal of Metallurgical In-dustry Medicine, 33(02):190-191.
24. Zhai QK, Zhong XM, Xiong ZY (2008). Clinical effects of combining mosapride with mecobalamin in diabetic gastropare-sis. Chinese Journal of Modern Medicine, 05:46.
25. Zhao XJ (2016). Effects of combining mecobalamin and mosapride in diabetic gastroparesis. Journal of Contemporary Medi-cine, 14(09):176-177.
26. Zhao XL, Guo WJ (2016). Efficacy observa-tion of mosapride combined with meco-balamin in senile diabetic gastroparesis. Chinese Convalescent Medicine, 25(06):647-648.
27. Zhu YB (2008). Effects of combining trimebutin maleate with mecobalamin in diabetic gastroparesis. Qingdao Medical and Health, 50(01):44-46.
28. Achem-Karam SR, Funakoshi A, Vinik Al et al (1985): Plasma motilin concentration and interdigestive migrating motor com-plex in diabetic gastroparesis: effect of metoclopramide. Gastroenterology, 88:492-499.
| Files | ||
| Issue | Vol 50 No 11 (2021) | |
| Section | Review Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v50i11.7570 | |
| Keywords | ||
| Mecobalamin Prokinetic agents Diabetic gastroparesis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
